Depression is one of the most common mental health conditions in the United States, and yet it can feel deeply isolating when you’re the one living with it. If you’ve been dealing with low energy, a loss of interest in things you used to enjoy, or a heavy sadness you can’t shake, you’re not alone. And if you’ve already tried therapy, medication, or both and still don’t feel better, you may be living with treatment-resistant depression, a more stubborn form of depression that needs a different approach.
Some types of depression simply don’t respond to traditional treatment. Treatment-resistant depression isn’t a reflection of how hard you’ve tried or how strong you are. It’s a recognized clinical condition that benefits from specialized, evidence-based care.
What is treatment-resistant depression?
Treatment-resistant depression (TRD) is a form of major depressive disorder that hasn’t improved after at least two different antidepressant medications, taken at the correct dose for an adequate period of time. It’s not a separate diagnosis. Rather, it’s a way of describing depression that doesn’t respond to standard first-line treatments.
TRD is more common than many people realize. According to research, treatment-resistant depression affects about 30% of people diagnosed with major depressive disorder.
Many people living with TRD have spent years cycling through different medications, adjusting doses, switching providers, or being told to “just hang in there.” The condition is real, and so are the treatments designed for it.
How is treatment-resistant depression different from regular depression?
The biggest difference between depression and TRD lies in how the brain responds to treatment. With typical depression, medications that target serotonin, norepinephrine, or other mood-related chemicals often bring meaningful relief over time. With TRD, those same medications may not help at all, or they may help briefly before symptoms return.
Symptoms of TRD look similar to those of major depressive disorder:
- Persistent sadness or emptiness
- Loss of interest in activities you used to enjoy
- Fatigue or low energy
- Difficulty sleeping or sleeping too much
- Changes in appetite or weight
- Feelings of worthlessness or hopelessness
- Trouble concentrating or making decisions
- Thoughts of death or suicide
The difference is duration and treatment response. If these symptoms have continued despite multiple medication trials, your provider may consider a TRD diagnosis and explore treatments that work through different mechanisms.
Why doesn’t standard treatment work for some people?
Researchers are still studying why some people don’t respond to traditional antidepressants, but several factors appear to play a role. Genetics influence how your body metabolizes certain medications, which is why two people on the same drug can have very different results. Other factors include co-occurring conditions like anxiety or chronic pain, unaddressed trauma, hormonal changes, and differences in brain chemistry that aren’t fully captured by serotonin-based medications.
What’s clear from the research is that the more medications you try without success, the less likely each new one is to work. Each trial of a new antidepressant decreases the chances of depression remission, dropping to just 7% after a fourth round.
This is why it’s important to recognize TRD early and explore treatments designed specifically for it, rather than continuing to cycle through medications with diminishing returns.
How is treatment-resistant depression treated?
Treatments for TRD work differently from standard antidepressants. Instead of focusing primarily on serotonin, they target other systems in the brain or use non-medication approaches to stimulate areas involved in mood regulation. Two of the most well-established options are transcranial magnetic stimulation (TMS) and Spravato® (esketamine).
TMS therapy: A non-invasive, medication-free option
Transcranial magnetic stimulation (TMS) is an FDA-approved treatment that uses gentle magnetic pulses to stimulate the areas of the brain involved in mood regulation. It’s non-invasive, requires no anesthesia, and has no recovery time. Patients can drive themselves to and from appointments and return to their day immediately afterward.
TMS works by “waking up” under-active nerve cells in the brain’s prefrontal cortex, encouraging the brain to form stronger neural connections over time. For many people with treatment-resistant depression, TMS offers a path forward when medications haven’t worked.
In one clinical study, 58% of patients experienced significant improvement in their depression symptoms with TMS, and 37% reached full remission.
Pacific Mind Health offers several TMS options to fit different schedules and needs, including standard sessions (20–40 minutes daily over six weeks), Express TMS (3-minute sessions over six weeks), Accelerated TMS (condenses treatment into about a week), and even One-Day TMS.
Spravato (esketamine): A fast-acting nasal spray
Spravato is an FDA-approved nasal spray developed specifically for treatment-resistant depression. Unlike traditional antidepressants that affect serotonin, Spravato targets glutamate, a different chemical messenger involved in how brain cells communicate. This different mechanism is why it can bring relief much faster than standard medications, sometimes within hours or days.
Spravato is self-administered under medical supervision in a certified treatment center, with a two-hour monitoring period after each dose. It’s typically used alongside an oral antidepressant for the best results.
What should I do if I think I have treatment-resistant depression?
If you’ve tried multiple antidepressants without meaningful relief, the next step is talking to a psychiatrist who specializes in interventional treatments. A specialist can review your treatment history, confirm whether TRD is the right framework for what you’re experiencing, and walk you through options that go beyond standard medication management.
You don’t have to keep cycling through medications hoping the next one will work. Treatment-resistant depression has dedicated, effective therapies, and finding the right care team is often the turning point.
If you or someone you know is in crisis, call or text 988 to reach the Suicide and Crisis Lifeline.
Frequently asked questions
How do I know if I have treatment-resistant depression?
Treatment-resistant depression is generally diagnosed when someone has tried at least two different antidepressants at adequate doses and durations without meaningful improvement. If that sounds like your experience, talk to a psychiatrist who can review your history and discuss next steps. A formal evaluation is the best way to know for sure.
Is treatment-resistant depression permanent?
No. TRD describes how depression has responded to traditional treatments so far. It’s not a life sentence. Many people who didn’t respond to standard antidepressants experience meaningful relief with treatments like TMS or Spravato. Working with a specialist can help identify the right approach for you.
How quickly can TMS or Spravato work for TRD?
The timelines differ. Spravato can bring relief within hours or days, though full benefits typically build over several weeks of treatment. TMS works more gradually, with most people noticing improvement within two to four weeks of starting daily sessions. Individual experiences vary.
Does insurance cover treatment for TRD?
Most insurance plans cover both TMS and Spravato for treatment-resistant depression. However, some plans may require pre-authorization. Pacific Mind Health’s team can help verify your coverage and walk you through the process.
Can I keep taking my current antidepressant while doing TMS or Spravato?
In most cases, yes. TMS is often used alongside ongoing medication, and Spravato is typically prescribed in combination with an oral antidepressant. Your provider will work with you to coordinate treatment in a way that supports your overall care plan.
Looking for mental health care services near you?
Pacific Mind Health offers medication management, therapy, and interventional treatments like transcranial magnetic stimulation (TMS) and ketamine and Spravato (esketamine).
Located in Southern California and serving patients across the state, Pacific Mind Health was founded by Joshua Flatow, MD, a board-certified psychiatrist and published peer-reviewed research author.
Ready to take the next step? Schedule a free consultation and start your mental health journey today.
